Repository logo
 
Publication

The impact of implementing an allergic rhinitis clinical management pathway (AR-CMaP) in the community pharmacy

2023Journal article Open access
Simple item page
dc.contributor.authorHouse, Rachel
dc.contributor.authorKritikos, Vicky
dc.contributor.authorCvetkovski, Biljana
dc.contributor.authorRimmer, Janet
dc.contributor.authorYan, Kwok
dc.contributor.authorCheong, Lynn
dc.contributor.authorBousquet, Jean
dc.contributor.authorLourenço, Olga
dc.contributor.authorBosnic-Anticevich, Sinthia
dc.date.accessioned2023-10-18T09:40:19Z
dc.date.available2023-10-18T09:40:19Z
dc.date.issued2023
dc.description.abstractBackground The Allergic Rhinitis Clinical Management Pathway (AR-CMaP) was developed to overcome the challenge of implementing current AR guidelines in the Australian community pharmacy practice and support pharmacists in optimally managing patients' AR. Objective(s) To evaluate the impact of AR-CMaP on patients' behaviour and pharmacists' needs in managing AR in the pharmacy. Methods This study used a cross-sectional, pre-post study design in which the primary outcome was the appropriateness of medications purchased from community pharmacies in Australia. Patient data were collected before and after the implementation of AR-CMaP. Pharmacist needs were recorded before and after AR-CMaP training. Data were analysed descriptively. Results Six pharmacies, 19 pharmacists and a total of 416 patients were included in the study; 206 pre-AR-CMaP implementation and 210 post-AR-CMaP implementation. Pre-AR-CMaP, 22.4% of patients purchased appropriate AR medication compared with 29.0% post-AR-CMaP implementation. Over half the patient cohort (52%) consulted a pharmacist pre-AR-CMaP and 37% consulted a pharmacist post-AR-CMaP implementation. Post-AR-CMaP, pharmacists reported increased awareness of barriers such as patients' lack of time, patients' perceptions about the pharmacist's role and patient choice to self-manage. Pharmacists also rated an increased desire to interact with other health care providers (HCPs) in caring for patients with AR. Conclusions While there was a non-statistically significant increase in the proportion of patients purchasing optimal AR medication, AR-CMaP did empower patients to self-select their own medication without further detriment. Moreover, following the implementation of AR-CMaP, pharmacists developed a greater awareness of their role in AR management, exemplified by their increased desire to be actively involved in AR management and increased interaction with other HCPs. Future research needs to explore more effective tools to support pharmacists' clinical decision-making and target patients' self-selection of AR medications. This study highlights that there is an ingrained self-reliance of AR decision-making that has become a habit for people living with AR.pt_PT
dc.description.sponsorshipThis study is partly supported through an Investigator-Initiated Woolcock-Mylan Partnership Grant 001984.pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.doi10.1016/j.rcsop.2023.100340pt_PT
dc.identifier.urihttp://hdl.handle.net/10400.6/13437
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/pt_PT
dc.subjectAllergic rhinitispt_PT
dc.subjectPharmacistpt_PT
dc.subjectCommunity pharmacypt_PT
dc.subjectGuidelinept_PT
dc.subjectSelf-selectpt_PT
dc.subjectSuboptimal managementpt_PT
dc.titleThe impact of implementing an allergic rhinitis clinical management pathway (AR-CMaP) in the community pharmacypt_PT
dc.typejournal article
dspace.entity.typePublication
oaire.citation.startPage100340pt_PT
oaire.citation.titleExploratory Research in Clinical and Social Pharmacypt_PT
oaire.citation.volume12pt_PT
person.familyNameHouse
person.familyNameKritikos
person.familyNameRimmer
person.familyNameYan
person.familyNameCheong
person.familyNameBousquet
person.familyNameLourenço
person.familyNameBosnic-Anticevich
person.givenNameRachel
person.givenNameVicky
person.givenNameJanet
person.givenNameKwok
person.givenNameLynn
person.givenNameJean
person.givenNameOlga Maria Marques
person.givenNameSinthia
person.identifier.ciencia-id6D1F-B555-DD1B
person.identifier.ciencia-id6618-1C4C-D1B7
person.identifier.orcid0000-0003-2176-0431
person.identifier.orcid0000-0003-3955-0002
person.identifier.orcid0000-0001-6014-2367
person.identifier.orcid0000-0002-0405-0780
person.identifier.orcid0000-0001-8426-0667
person.identifier.orcid0000-0002-4061-4766
person.identifier.orcid0000-0002-8401-5976
person.identifier.orcid0000-0001-5077-8329
person.identifier.scopus-author-id9745699500
person.identifier.scopus-author-id55577111700
rcaap.rightsopenAccesspt_PT
rcaap.typearticlept_PT
relation.isAuthorOfPublication446df251-074a-48ae-b64d-965af717b616
relation.isAuthorOfPublicationcbe4def2-c29e-489f-8d05-ca04e6f5bdf8
relation.isAuthorOfPublication6b175b8c-fae2-4f38-9795-465fcbaf8cb2
relation.isAuthorOfPublication87f8028e-fbc6-4a61-baed-0947ba51c545
relation.isAuthorOfPublication68b8ce25-ec49-4478-ad04-db6d0331f011
relation.isAuthorOfPublication50a12f1e-371a-4efe-bf31-df198fffeaca
relation.isAuthorOfPublicationc890c74a-abc1-4910-aa70-f0da7b4ad902
relation.isAuthorOfPublication17bf1792-077d-46cf-9bf4-c97a9b84d167
relation.isAuthorOfPublication.latestForDiscovery50a12f1e-371a-4efe-bf31-df198fffeaca

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
2023_House R_ERCSP.pdf
Size:
2.15 MB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

ICI - CICS | Documentos por Auto-Depósito
FCS - DCM | Documentos por Auto-Depósito